|
|
||||||||
The Journal of Immunology, Vol 148, Issue 11 3478-3482, Copyright © 1992 by American Association of Immunologists
ARTICLES |
CA Lamb and P Cresswell
Section of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510.
The MHC class II-associated invariant chain behaves as a resident endoplasmic reticulum protein in the absence of class II molecules. In humans, two predominant forms exist; one, p35, differs from the other, p33, by an N-terminal cytoplasmic extension of 16 amino acids that contains a strong endoplasmic reticulum-retention signal. Here we show that one mechanism for retention of p33 is its association with p35 in mixed invariant chain trimers. However, even for p33 homotrimers transport from the endoplasmic reticulum is inefficient. In an MHC class II-positive B cell line, the formation of invariant chain trimers is rapid and is the first intermediate in the assembly of a nine-chain alpha beta-invariant chain complex. With time, three higher molecular weight complexes are progressively formed. These correspond to an invariant chain trimer with one alpha beta dimer, two alpha beta dimers, and three alpha beta dimers, respectively. No free alpha beta dimers are detectable early in biosynthesis. However, beginning at 2 h of chase, alpha beta dimers begin to appear concomitant with the disappearance of the completely assembled alpha beta-invariant chain complex. This conversion is virtually complete by 4 h, and presumably reflects the proteolytic degradation of the invariant chain component of the alpha beta-invariant chain complex and the generation of endosomal alpha beta dimers capable of binding antigenic peptides.
This article has been cited by other articles:
![]() |
X. Chen, X. Wang, J. M. Keaton, F. Reddington, P. A. Illarionov, G. S. Besra, and J. E. Gumperz Distinct Endosomal Trafficking Requirements for Presentation of Autoantigens and Exogenous Lipids by Human CD1d Molecules J. Immunol., May 15, 2007; 178(10): 6181 - 6190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van Lith and A. M. Benham The DM{alpha} and DMbeta Chain Cooperate in the Oxidation and Folding of HLA-DM J. Immunol., October 15, 2006; 177(8): 5430 - 5439. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Khalil, A. Brunet, and J. Thibodeau A three-amino-acid-long HLA-DR{beta} cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35 J. Cell Sci., October 15, 2005; 118(20): 4679 - 4687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dugast, H. Toussaint, C. Dousset, and P. Benaroch AP2 Clathrin Adaptor Complex, but Not AP1, Controls the Access of the Major Histocompatibility Complex (MHC) Class II to Endosomes J. Biol. Chem., May 20, 2005; 280(20): 19656 - 19664. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Burton, S. Ely, P. K. Reddy, R. Stein, D. V. Gold, T. M. Cardillo, and D. M. Goldenberg CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy Clin. Cancer Res., October 1, 2004; 10(19): 6606 - 6611. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stumptner-Cuvelette, M. Jouve, J. Helft, M. Dugast, A.-S. Glouzman, K. Jooss, G. Raposo, and P. Benaroch Human Immunodeficiency Virus-1 Nef Expression Induces Intracellular Accumulation of Multivesicular Bodies and Major Histocompatibility Complex Class II Complexes: Potential Role of Phosphatidylinositol 3-Kinase Mol. Biol. Cell, December 1, 2003; 14(12): 4857 - 4870. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Gregers, B. Fleckenstein, F. Vartdal, P. Roepstorff, O. Bakke, and I. Sandlie MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation Int. Immunol., November 1, 2003; 15(11): 1291 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Khalil, A. Brunet, I. Saba, R. Terra, R. P. Sekaly, and J. Thibodeau The MHC class II {beta} chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal Int. Immunol., October 1, 2003; 15(10): 1249 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yan, L. Shi, A. Penfornis, and D. L. Faustman Impaired Processing and Presentation by MHC Class II Proteins in Human Diabetic Cells J. Immunol., January 1, 2003; 170(1): 620 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Cebulla, D. M. Miller, Y. Zhang, B. M. Rahill, P. Zimmerman, J. M. Robinson, and D. D. Sedmak Human Cytomegalovirus Disrupts Constitutive MHC Class II Expression J. Immunol., July 1, 2002; 169(1): 167 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Patil, A. Pashine, M. P. Belmares, W. Liu, B. Kaneshiro, J. Rabinowitz, H. McConnell, and E. D. Mellins Rheumatoid Arthritis (RA)-Associated HLA-DR Alleles Form Less Stable Complexes with Class II-Associated Invariant Chain Peptide Than Non-RA-Associated HLA-DR Alleles J. Immunol., December 15, 2001; 167(12): 7157 - 7168. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Ramm, L Pond, C Watts, and W Stoorvogel Clathrin-coated lattices and buds on MHC class II compartments do not selectively recruit mature MHC-II J. Cell Sci., January 1, 2000; 113(2): 303 - 313. [Abstract] [PDF] |
||||
![]() |
M. W. Hofmann, S. Honing, D. Rodionov, B. Dobberstein, K. von Figura, and O. Bakke The Leucine-based Sorting Motifs in the Cytoplasmic Domain of the Invariant Chain Are Recognized by the Clathrin Adaptors AP1 and AP2 and their Medium Chains J. Biol. Chem., December 17, 1999; 274(51): 36153 - 36158. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Anderson, D. T. Bergstralh, T. Kawamura, A. Blauvelt, and P. A. Roche Phosphorylation of the Invariant Chain by Protein Kinase C Regulates MHC Class II Trafficking to Antigen-Processing Compartments J. Immunol., November 15, 1999; 163(10): 5435 - 5443. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Davidson Direct Transport of Newly Synthesized HLA-DR from the trans-Golgi Network to Major Histocompatibility Complex Class II Containing Compartments (MIICS) Demonstrated Using a Novel Tyrosine-sulfated Chimera J. Biol. Chem., September 17, 1999; 274(38): 27315 - 27322. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Ashman and J. Miller A Role for the Transmembrane Domain in the Trimerization of the MHC Class II-Associated Invariant Chain J. Immunol., September 1, 1999; 163(5): 2704 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Calvo, D. W. Frank, B. M. Bieler, J. F. Berson, and M. S. Marks A Cytoplasmic Sequence in Human Tyrosinase Defines a Second Class of Di-leucine-based Sorting Signals for Late Endosomal and Lysosomal Delivery J. Biol. Chem., April 30, 1999; 274(18): 12780 - 12789. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Wilson, P. Wolf, H. Ploegh, L. Ignatowicz, J. Kappler, and P. Marrack Invariant Chain Can Bind MHC Class II at a Site Other Than the Peptide Binding Groove J. Immunol., November 1, 1998; 161(9): 4777 - 4784. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Schafer, S. Malapati, K. K. Hanfelt, and S. K. Pierce The Assembly and Stability of MHC Class II-({alpha}{beta})2 Superdimers J. Immunol., September 1, 1998; 161(5): 2307 - 2316. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Escola, M. J. Kleijmeer, W. Stoorvogel, J. M. Griffith, O. Yoshie, and H. J. Geuze Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes J. Biol. Chem., August 7, 1998; 273(32): 20121 - 20127. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kang, L. Liang, C. D. Parker, and J. F. Collawn Structural Requirements for Major Histocompatibility Complex Class II Invariant Chain Endocytosis and Lysosomal Targeting J. Biol. Chem., August 7, 1998; 273(32): 20644 - 20652. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Anderson and P. A. Roche Phosphorylation Regulates the Delivery of MHC Class II Invariant Chain Complexes to Antigen Processing Compartments J. Immunol., May 15, 1998; 160(10): 4850 - 4858. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang and R. D. Salter Distinct Patterns of Folding and Interactions with Calnexin and Calreticulin in Human Class I MHC Proteins with Altered N-Glycosylation J. Immunol., January 15, 1998; 160(2): 831 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gedde-Dahl, I. Freisewinkel, M. Staschewski, K. Schenck, N. Koch, and O. Bakke Exon 6Is Essential for Invariant Chain Trimerization and Induction of Large Endosomal Structures J. Biol. Chem., March 28, 1997; 272(13): 8281 - 8287. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Barois, F. Forquet, and J. Davoust Selective Modulation of the Major Histocompatibility Complex Class II Antigen Presentation Pathway following B Cell Receptor Ligation and Protein Kinase C Activation J. Biol. Chem., February 7, 1997; 272(6): 3641 - 3647. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Denzin, C. Hammond, and P. Cresswell HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules J. Exp. Med., December 15, 1996; 184(6): 2153 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Wright, T. L. Moore, B. J. Vilen, A. M. Brown, and , J. P.-Y. Ting Major Histocompatibility Complex Class II-associated Invariant Chain Gene Expression Is Up-regulated by Cooperative Interactions of Sp1 and NF-Y J. Biol. Chem., September 8, 1995; 270(36): 20978 - 20986. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tector and R. D. Salter Calnexin Influences Folding of Human Class I Histocompatibility Proteins but Not Their Assembly with beta(2)-Microglobulin J. Biol. Chem., August 18, 1995; 270(33): 19638 - 19642. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Marks, R. N. Germain, and J. S. Bonifacino Transient Aggregation of Major Histocompatibility Complex Class II Chains during Assembly in Normal Spleen Cells J. Biol. Chem., May 5, 1995; 270(18): 10475 - 10481. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, M. Tector, and R. D. Salter Calnexin Recognizes Carbohydrate and Protein Determinants of Class I Major Histocompatibility Complex Molecules J. Biol. Chem., February 24, 1995; 270(8): 3944 - 3948. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Gorvel, J.-M. Escola, E. Stang, and O. Bakke Invariant Chain Induces a Delayed Transport from Early to Late Endosomes J. Biol. Chem., February 10, 1995; 270(6): 2741 - 2746. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Arunachalam and P. Cresswell Molecular Requirements for the Interaction of Class II Major Histocompatibility Complex Molecules and Invariant Chain with Calnexin J. Biol. Chem., February 10, 1995; 270(6): 2784 - 2790. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sugita and M. B. Brenner Association of the Invariant Chain with Major Histocompatibility Complex Class I Molecules Directs Trafficking to Endocytic Compartments J. Biol. Chem., January 20, 1995; 270(3): 1443 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bremnes, T. Madsen, M. Gedde-Dahl, and O. Bakke An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization J. Cell Sci., July 1, 1994; 107(7): 2021 - 2032. [Abstract] [PDF] |
||||
![]() |
A Sette, S Ceman, R. Kubo, K Sakaguchi, E Appella, D. Hunt, T. Davis, H Michel, J Shabanowitz, R Rudersdorf, et al. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant Science, December 11, 1992; 258(5089): 1801 - 1804. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |